Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages

Parasite Immunology - Tập 24 Số 7 - Trang 339-345 - 2002
Anne Camille La Flamme1, Phillip Scott2, Edward J. Pearce3,1
1Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY and
2Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA. USA
3Current address: Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA.

Tóm tắt

Summary Infection of mice with Schistosoma mansoni delays the resolution of cutaneous lesions and parasitaemia during Leishmania major infection. In contrast, L. major infection does not appear to alter the course of schistosomiasis. Analysis of the cytokine responses in the draining lymph nodes (LN) indicates that, while L. major infection had no effect on schistosome‐specific interleukin (IL)‐4 production by mesenteric LN (MLN) cells, coinfection with S. mansoni resulted in decreased leishmania‐induced interferon (IFN)‐γ, tumour necrosis factor‐α and nitric oxide production by popliteal LN (PLN) cells 4 weeks after L. major infection. In addition, PLN cells produced higher levels of IL‐4 4 weeks after L. major infection in coinfected mice. Finally, IFN‐γ‐stimulated macrophages isolated from S. mansoni‐infected mice were impaired in their ability to kill L. major after in vitro infection. These results suggest that pre‐existence of a strong Th2 response‐dominated infection can alter the responses to Th1‐inducing pathogens at peripheral sites and impair Th1‐mediated effector functions.

Từ khóa


Tài liệu tham khảo

Butterworth AE, 1994, Immunity and morbidity in human schistosomiasis mansoni, Trop Geogr Med, 46, 197

WHO., 1990, Control of Leishmaniasis: Report of a WHO Expert Committee.

10.1146/annurev.iy.13.040195.001055

10.4049/jimmunol.146.4.1322

10.4049/jimmunol.159.2.777

10.1111/j.1365-3024.1985.tb00098.x

10.1084/jem.132.3.488

Scott P, 1987, Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract, J Immunol, 139, 3118, 10.4049/jimmunol.139.9.3118

10.1111/j.1365-3083.1994.tb03333.x

10.1016/0003-2697(82)90118-X

10.1016/0022-1759(87)90497-2

10.1016/0022-1759(89)90198-1

10.1084/jem.184.5.1871

Liew FY, 1990, Tumor necrosis factor‐alpha synergizes with IFN‐gamma in mediating killing of Leishmania major through the induction of nitric oxide, J Immunol, 145, 4306, 10.4049/jimmunol.145.12.4306

10.1038/375408a0

Green SJ, 1990, Leishmania major amastigotes initiate the 1‐arginine‐dependent killing mechanism in IFN‐gamma‐stimulated macrophages by induction of tumor necrosis factor‐alpha, J Immunol, 145, 4290, 10.4049/jimmunol.145.12.4290

Juttner S, 1998, Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF‐alpha, J Immunol, 161, 2383, 10.4049/jimmunol.161.5.2383

Marshall AJ, 1999, Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF‐alpha and early death in C57BL/6 mice, J Immunol, 163, 2089, 10.4049/jimmunol.163.4.2089

10.1084/jem.181.2.769

Sadick MD, 1991, Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice, Infect Immun, 59, 4710, 10.1128/iai.59.12.4710-4714.1991

10.1084/jem.173.1.159

10.1126/science.1636092

10.1002/eji.1830270409

10.1086/515297